We are live on ! Find out more
VIVS

VivoSim Labs
VIVS

38 hedge funds and large institutions have $2.64M invested in VivoSim Labs in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 12 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

0.13% less ownership

Funds ownership: 1.92% → 1.79% (-0.13%)

3% less funds holding

Funds holding: 39 → 38 (-1)

35% less capital invested

Capital invested by funds: $4.07M → $2.64M (-$1.43M)

50% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 12

Holders
38
Holders Change
-1
Holders Change %
-2.56%
% of All Funds
0.61%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
6
Reduced
12
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Rockefeller Capital Management
Rockefeller Capital Management
New York
+$840
2
NA
NewEdge Advisors
Louisiana
+$680
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$620
4
Vanguard Group
Vanguard Group
Pennsylvania
+$240
5
JP Morgan Chase
JP Morgan Chase
New York
+$180

Top Sellers

Rank Fund Capital Flow
1
AIM
ARK Investment Management
Florida
-$101K
2
Millennium Management
Millennium Management
New York
-$50K
3
VF
Virtu Financial
New York
-$30K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$23K
5
Renaissance Technologies
Renaissance Technologies
New York
-$13.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
NAMA
1
Nikko Asset Management Americas
New York
$641K -$11K -552 -1%
Sumitomo Mitsui Trust Group
2
Sumitomo Mitsui Trust Group
Japan
$641K -$11K -552 -1%
Vanguard Group
3
Vanguard Group
Pennsylvania
$399K +$240 +12 +0.1%
AIM
4
ARK Investment Management
Florida
$302K -$101K -5,047 -22%
BlackRock
5
BlackRock
New York
$208K -$300 -15 -0.1%
Renaissance Technologies
6
Renaissance Technologies
New York
$158K -$13.1K -653 -7%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$91K -$240 -12 -0.2%
Susquehanna International Group
8
Susquehanna International Group
Pennsylvania
$72K +$620 +31 +0.7%
Morgan Stanley
9
Morgan Stanley
New York
$47.5K -$280 -14 -0.5%
State Street
10
State Street
Massachusetts
$39.5K – – –
Northern Trust
11
Northern Trust
Illinois
$20.7K +$20 +1 +0.1%
UBS Group
12
UBS Group
Switzerland
$5.92K -$3.4K -170 -33%
Osaic Holdings
13
Osaic Holdings
Arizona
$4.28K -$380 -19 -8%
Russell Investments Group
14
Russell Investments Group
United Kingdom
$3.57K – – –
AFG
15
Albion Financial Group
Utah
$2.7K – – –
PMFA
16
Plante Moran Financial Advisors
Michigan
$2.19K – – –
TRCT
17
Tower Research Capital (TRC)
New York
$2K -$2.36K -118 -51%
US Bancorp
18
US Bancorp
Minnesota
$705 – – –
Wells Fargo
19
Wells Fargo
California
$606 +$20 +1 +3%
Bank of America
20
Bank of America
North Carolina
$458 +$40 +2 +8%
KFS
21
Kelly Financial Services
Massachusetts
$237 – – –
AWM
22
Activest Wealth Management
Florida
$178 – – –
HI
23
Harbour Investments
Wisconsin
$173 – – –
Credit Agricole
24
Credit Agricole
France
$141 – – –
CFB
25
Cullen/Frost Bankers
Texas
$56 – – –
1
2

VIVS Hedge Fund Activity: Q4 2022 in Review

38 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in VivoSim Labs (VIVS) for Q4 2022, worth a combined $2.64M — down 35% from $4.07M a quarter earlier.

Fund positioning in VIVS was balanced in Q4 2022: 4 funds opened new positions, 4 closed out, 6 added to existing stakes and 12 trimmed.

The largest buyer was Rockefeller Capital Management, opening a new position worth an estimated $840. The largest seller was ARK Investment Management, cutting an estimated $101K.

  • 38 institutional investors held VivoSim Labs (VIVS) as of Q4 2022, down from 39 in Q3 2022.
  • Funds reported $2.64M of VivoSim Labs stock for Q4 2022, down 35% quarter-over-quarter.
  • 4 funds opened new VivoSim Labs positions in Q4 2022 and 4 closed out, a net change of 0 holders.
  • The largest VivoSim Labs buyer in Q4 2022 was Rockefeller Capital Management, an estimated $840 added.
  • The largest VivoSim Labs seller in Q4 2022 was ARK Investment Management, an estimated $101K sold.

Based on aggregated 13F filings for Q4 2022.